Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2005-5-10
pubmed:abstractText
To examine the association of plasma cholesterol levels, lipid-lowering agent (LLA) intake, and APOE genotype with dementia prevalence.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1531-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15883313-Aged, pubmed-meshheading:15883313-Aged, 80 and over, pubmed-meshheading:15883313-Apolipoprotein E4, pubmed-meshheading:15883313-Apolipoproteins E, pubmed-meshheading:15883313-Causality, pubmed-meshheading:15883313-Cholesterol, pubmed-meshheading:15883313-Clofibric Acid, pubmed-meshheading:15883313-Cohort Studies, pubmed-meshheading:15883313-Cross-Sectional Studies, pubmed-meshheading:15883313-Dementia, pubmed-meshheading:15883313-Female, pubmed-meshheading:15883313-France, pubmed-meshheading:15883313-Genetic Predisposition to Disease, pubmed-meshheading:15883313-Genetic Testing, pubmed-meshheading:15883313-Genotype, pubmed-meshheading:15883313-Health Surveys, pubmed-meshheading:15883313-Humans, pubmed-meshheading:15883313-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15883313-Hyperlipidemias, pubmed-meshheading:15883313-Hypolipidemic Agents, pubmed-meshheading:15883313-Male, pubmed-meshheading:15883313-Prospective Studies, pubmed-meshheading:15883313-Questionnaires
pubmed:year
2005
pubmed:articleTitle
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
pubmed:affiliation
Institut National de la Santé et de la Recherche Médicale U360, Hopital La Salpêtrière, Paris, France. carole.dufouil@chups.jussieu.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study